CNSP
CNS PharmaceuticalsยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
CNSP Profile
Cns Pharmaceuticals, Inc.
A company that developing anticancer drug candidates for the treatment of brain and central nervous system tumors
2100 West Loop South, Suite 900, Houston, TX 77027
--
CNS Pharmaceuticals, Inc.is a clinical pharmaceutical company formed on July 27, 2017 as a Nevada company focused on the development of anticancer drug candidates for the treatment of brain and central nervous system tumors, The Company is based on intellectual property licensed under license agreements with Houston Pharma Corporation (" HPI ") and The University of Texas MD Anderson Cancer Center (" UTMDACC ") and owned under a collaboration and asset purchase agreement with Reata Pharmaceuticals, Inc. (" Reata ").
